These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2816471)

  • 1. Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid.
    Roy A; Pickar D; Gold P; Barbaccia M; Guidotti A; Costa E; Linnoila M
    Acta Psychiatr Scand; 1989 Sep; 80(3):287-91. PubMed ID: 2816471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls.
    Roy A
    Neuropharmacology; 1991 Dec; 30(12B):1441-4. PubMed ID: 1780040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF diazepam-binding inhibitor in alcoholics and normal controls.
    Roy A; DeJong J; Adinoff B; Barbaccia M; Costa E; Guidotti A; Linnoila M
    Psychiatry Res; 1990 Mar; 31(3):261-6. PubMed ID: 2333358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF GABA and neuropeptides in pathological gamblers and normal controls.
    Roy A; DeJong J; Ferraro T; Adinoff B; Gold P; Rubinow D; Linnoila M
    Psychiatry Res; 1989 Nov; 30(2):137-44. PubMed ID: 2616683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence.
    Adinoff B; Anton R; Linnoila M; Guidotti A; Nemeroff CB; Bissette G
    Neuropsychopharmacology; 1996 Sep; 15(3):288-95. PubMed ID: 8873112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.
    Roy A; Pickar D; Linnoila M; Chrousos GP; Gold PW
    Psychiatry Res; 1987 Mar; 20(3):229-37. PubMed ID: 3495811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
    Roy A; Pickar D; Paul S; Doran A; Chrousos GP; Gold PW
    Am J Psychiatry; 1987 May; 144(5):641-5. PubMed ID: 3495188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF diazepam-binding inhibitor concentrations in panic disorder.
    Payeur R; Lydiard RB; Ballenger JC; Laraia MT; Fossey MD; Zealberg J
    Biol Psychiatry; 1992 Oct; 32(8):712-6. PubMed ID: 1333825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
    Geracioti TD; Loosen PT; Orth DN
    Biol Psychiatry; 1997 Aug; 42(3):165-74. PubMed ID: 9232208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD; Orth DN; Ekhator NN; Blumenkopf B; Loosen PT
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1325-30. PubMed ID: 1317385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides in relation to suicidal behavior in depression.
    Roy A
    Neuropsychobiology; 1993; 28(4):184-6. PubMed ID: 7903797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease.
    Barbaccia ML; Costa E; Ferrero P; Guidotti A; Roy A; Sunderland T; Pickar D; Paul SM; Goodwin FK
    Arch Gen Psychiatry; 1986 Dec; 43(12):1143-7. PubMed ID: 3022663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
    Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.
    De Bellis MD; Gold PW; Geracioti TD; Listwak SJ; Kling MA
    Am J Psychiatry; 1993 Apr; 150(4):656-7. PubMed ID: 8465888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
    Wong ML; Kling MA; Munson PJ; Listwak S; Licinio J; Prolo P; Karp B; McCutcheon IE; Geracioti TD; DeBellis MD; Rice KC; Goldstein DS; Veldhuis JD; Chrousos GP; Oldfield EH; McCann SM; Gold PW
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):325-30. PubMed ID: 10618417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM; Bissette G; Arato M; O'Connor L; Nemeroff CB
    Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazepam binding inhibitor-like immunoreactivity (DBI-LI) in human CSF. Correlations with neurological disorders.
    Ferrero P; Benna P; Costa P; Tarenzi L; Baggio G; Bergamasco B; Bergamini L
    J Neurol Sci; 1988 Nov; 87(2-3):327-49. PubMed ID: 3210041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder.
    Geracioti TD; Baker DG; Kasckow JW; Strawn JR; Jeffrey Mulchahey J; Dashevsky BA; Horn PS; Ekhator NN
    Psychoneuroendocrinology; 2008 May; 33(4):416-24. PubMed ID: 18295412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy.
    Rothstein JD; McKhann G; Guarneri P; Barbaccia ML; Guidotti A; Costa E
    Ann Neurol; 1989 Jul; 26(1):57-62. PubMed ID: 2549847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.